Analgesic compounds for treatment of pain or fever that include a bicyclopentane moiety linked to an amine, combinations of the compounds with opioid analgesic drugs, and methods for treating pain or fever by administering a compound described herein.

Analgesic compounds for treatment of pain or fever that include a bicyclopentane moiety linked to an amine, combinations of the compounds with opioid analgesic drugs, and methods for treating pain or fever by administering a compound described herein.

Methods for producing mesoporous zeolites are provided. In some embodiments, the method includes mixing a silicon-containing material, an aluminum-containing material, or both, with a quaternary amine and at least one base to produce a zeolite precursor solution. The zeolite precursor solution is combined with nanocellulose to form a zeolite precursor gel, from which volatiles are removed. The zeolite precursor gel is crystallized to produce a crystalline zeolite intermediate. The crystalline zeolite intermediate is calcined to form the mesoporous zeolite. The nanocellulose mesopores template may include cellulose nanocrystals, nanocellulose fibers, or combinations thereof. The quaternary amine may include tetraethylammonium hydroxide, tetraethylamonnium alkoxide, tetrapropylammonium alkoxide, other alkaline materials comprising ammonium, or combinations thereof.

Methods for producing mesoporous zeolites are provided. In some embodiments, the method includes mixing a silicon-containing material, an aluminum-containing material, or both, with a quaternary amine and at least one base to produce a zeolite precursor solution. The zeolite precursor solution is combined with nanocellulose to form a zeolite precursor gel, from which volatiles are removed. The zeolite precursor gel is crystallized to produce a crystalline zeolite intermediate. The crystalline zeolite intermediate is calcined to form the mesoporous zeolite. The nanocellulose mesopores template may include cellulose nanocrystals, nanocellulose fibers, or combinations thereof. The quaternary amine may include tetraethylammonium hydroxide, tetraethylamonnium alkoxide, tetrapropylammonium alkoxide, other alkaline materials comprising ammonium, or combinations thereof.

This invention relates to aqueous compositions for hair treatment, comprising polyorganosiloxanes A) having di- and trihydroxy-substituted aromatic groups and at least one surfactant B) selected from cationic surfactants B1) and anionic surfactants B2) in a certain weight ratio of the surfactant B) to the polyorganosiloxane A), and said aqueous compositions having a certain pH. The invention further relates to hair treatment compositions, comprising said aqueous compositions and to hair treatment processes using said aqueous compositions or hair treatment compositions.

The present invention relates to cationic compounds of formula (I) for use as peripheral NMDA receptor antagonists.

##STR00001##

The present invention relates to cationic compounds of formula (I) for use as peripheral NMDA receptor antagonists.

##STR00001##

Disclosed herein are compositions for use in an energy providing devices and methods of preparing such devices. Also included herein is energy providing devices that comprise a charged compound modified substrate or zwitterion-modified substrate or energy providing devices that comprise an electrolyte that comprises a perhalogenatedphenyl azide charged or zwitterionic compound.

Disclosed herein are compositions for use in an energy providing devices and methods of preparing such devices. Also included herein is energy providing devices that comprise a charged compound modified substrate or zwitterion-modified substrate or energy providing devices that comprise an electrolyte that comprises a perhalogenatedphenyl azide charged or zwitterionic compound.

A resist composition comprising a base polymer and a phosphazene salt compound offers a high dissolution contrast, minimal LWR, and dimensional stability on PPD.